Todd Asset Management LLC boosted its holdings in Icon Plc (NASDAQ:ICLR) by 0.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 131,260 shares of the medical research company’s stock after buying an additional 1,103 shares during the period. Todd Asset Management LLC’s holdings in Icon were worth $17,927,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. WCM Investment Management LLC increased its position in shares of Icon by 5.4% during the fourth quarter. WCM Investment Management LLC now owns 5,272,086 shares of the medical research company’s stock valued at $681,207,000 after acquiring an additional 271,375 shares in the last quarter. Boston Partners increased its position in shares of Icon by 9.1% during the first quarter. Boston Partners now owns 1,503,804 shares of the medical research company’s stock valued at $205,390,000 after acquiring an additional 125,498 shares in the last quarter. Pendal Group Ltd increased its position in shares of Icon by 48,582.8% during the fourth quarter. Pendal Group Ltd now owns 1,405,471 shares of the medical research company’s stock valued at $181,601,000 after acquiring an additional 1,402,584 shares in the last quarter. Massachusetts Financial Services Co. MA increased its position in shares of Icon by 5.5% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 1,129,043 shares of the medical research company’s stock valued at $145,883,000 after acquiring an additional 58,724 shares in the last quarter. Finally, Westfield Capital Management Co. LP increased its position in shares of Icon by 8.4% during the fourth quarter. Westfield Capital Management Co. LP now owns 698,029 shares of the medical research company’s stock valued at $90,192,000 after acquiring an additional 54,150 shares in the last quarter. 87.65% of the stock is currently owned by institutional investors.

ICLR stock traded down $0.31 on Tuesday, hitting $136.97. The company had a trading volume of 2,816 shares, compared to its average volume of 302,138. Icon Plc has a 12-month low of $118.10 and a 12-month high of $155.33. The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $7.49 billion, a P/E ratio of 22.02, a P/E/G ratio of 1.89 and a beta of 0.62.

Icon (NASDAQ:ICLR) last issued its earnings results on Wednesday, May 1st. The medical research company reported $1.63 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.60 by $0.03. Icon had a net margin of 12.56% and a return on equity of 25.71%. The company had revenue of $674.85 million for the quarter, compared to analysts’ expectations of $668.93 million. During the same quarter last year, the company posted $1.44 earnings per share. The firm’s quarterly revenue was up 8.8% on a year-over-year basis. As a group, equities analysts predict that Icon Plc will post 6.87 earnings per share for the current year.

Several equities research analysts recently weighed in on ICLR shares. BidaskClub downgraded shares of Icon from a “hold” rating to a “sell” rating in a research report on Saturday, April 13th. Barclays raised their price target on shares of Icon from $130.00 to $140.00 and gave the company an “equal weight” rating in a research report on Thursday, February 21st. Zacks Investment Research upgraded shares of Icon from a “hold” rating to a “buy” rating and set a $155.00 target price on the stock in a report on Friday. Mizuho upgraded shares of Icon from a “neutral” rating to a “buy” rating and raised their target price for the stock from $146.00 to $150.00 in a report on Friday, January 25th. Finally, ValuEngine cut shares of Icon from a “buy” rating to a “hold” rating in a report on Tuesday, April 16th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and ten have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $153.20.

ILLEGAL ACTIVITY WARNING: This article was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another domain, it was stolen and reposted in violation of United States & international copyright and trademark law. The original version of this article can be read at https://www.watchlistnews.com/icon-plc-iclr-holdings-lifted-by-todd-asset-management-llc/3017895.html.

Icon Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. It specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.

Read More: What is a blue-chip stock?

Want to see what other hedge funds are holding ICLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Icon Plc (NASDAQ:ICLR).

Institutional Ownership by Quarter for Icon (NASDAQ:ICLR)

Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with MarketBeat.com's FREE daily email newsletter.